As the world watches the events of the United Nations Climate Change Conference 2021, in Glasgow, we examine if hemp could play a part in the reduction of carbon emissions. Earlier this year, the IPCC report on climate change revealed the shocking state of the environment
Businesses often require outside capital to finance operating activities and to enable scaling and growth. Financing in the cannabis industry is notoriously challenging with regulatory obstacles at the local, state and federal levels. Recent market dynamics pose additional challenges for both financiers and cannabis operators. We
Dr Niraj Singh, a consultant psychiatrist and prescriber at The Medical Cannabis Clinics discusses the important role that THC can play in treating mental illness. As a consultant psychiatrist in the NHS, Dr Niraj Singh treats patients with serious mental health conditions, from anxiety and depression
THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available to UK patients. Health Secretary Matt Hancock ordered an urgent review into the lack of cannabis prescriptions, last spring. The creation of
The post The battle of the bans: Is there any hope for cannabis brands on social media? appeared first on Cannabis Health News.
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in 2022 found that in the UK, while around 40,000 clinicians are eligible to prescribe medical cannabis, only
Mandrake. Perhaps you know it by some of its other names: Satan’s apple, Devil’s testicle, Circe’s plant. Or perhaps you thought it was just some fictional plant straight out of Harry Potter or some type of witches’ brew. You wouldn’t be too wrong about the last
Large study reveals no “hangover” effects, suggesting benefits are acute rather than long lasting, and that those with prior full-dose psychedelic experience showed enhanced creativity boosts This story first appeared on leafie, view here Author: Liam O’Dowd
Nearly three-quarters of medical cannabis patients report that cannabis outperforms conventional prescription sleep medications, according to a major European survey. The study, conducted by Frankfurt-based Bloomwell Group between December 2024 and March 2025, surveyed 1,086 people who have been using cannabis to aid sleep since 2023.
A long-term study of over 1,500 young people revealed that teenagers who start using cannabis before age 15 are at significantly higher risk of developing both mental and physical health problems requiring medical treatment in early adulthood. This story first appeared on leafie, view here Author:
Analysis released by Transform Drug Policy Foundation has shown that that legalising and regulating cannabis for adult non-medical use in the UK could generate up to £1.5 billion in annual net benefits to the Treasury. The report, titled High Returns: The Economic Benefits of UK Cannabis
Researchers at the University of California, Los Angeles have found that smoking cannabis does not carry the same risks as smoking tobacco. Longitudinal data published in the journal Chronic Obstructive Pulmonary Diseases found that cannabis use is not associated with an elevated risk of chronic obstructive
A study published in the Journal of American Medicine suggests that one dose of psilocybin, the active ingredient in magic mushrooms, can have a significant positive effect on participants living with major depressive disorder. The randomised, double-blind study was undertaken by a team of scientists from
Written by Releaf With medical cannabis showing promise among elderly patients, UK cannabis clinic, Releaf, examines its efficacy, safety profile, and other things to consider when exploring this treatment option for yourself or a loved one. Since medical cannabis was legalised in the UK almost six
A new cannabis trade organisation will help shape the next phase of the regulated cannabis sector on the British Isles. In a landmark development for the cannabis industry the Cannabis Services Advisory Board, has been established in Jersey to act as an official conduit between industry
Dalgety, a business based in Burton-on-Trent in Staffordshire which has recently been granted permission from the Home Office to grow and distribute cannabis for medicinal purposes, has former Labour Home Secretary Jacqui Smith sitting on its main board. Jacqui Smith was Home Secretary from 2007 to
The Levelling up secretary, Michael Gove, today announced that the government will ignore advice from its own drug advisory council and press ahead with a ban on laughing gas, also known as nitrous oxide. Gove announced the plans on the BBC political programme Sophy Ridge on
Research shows that oxidation, not contamination, is the leading cause of vape oil discoloration, according to a recent white paper from Abstrax Tech. Vape brands, particularly those producing high-end concentrates, have struggled to prevent product degradation in retail environments, where display refrigeration is often limited or
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The
Dying Matters Awareness Week encourages open conversations about end-of-life care, helping to break the stigma around death and dying. This year’s discussions feel particularly timely, as the UK’s Terminally Ill Adults (End of Life) Bill moves forward[1]. If passed, the bill could change the future of
As medical cannabis products have gained increasing attention throughout the world, and particularly in the UK, perhaps one of the most discussed areas of research is that of the potential of cannabinoids in Epilepsy treatments. In 2018, the government rescheduled cannabis following in response to evidence
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
Chronic pain affects millions of people in the UK. As the conversation around medical cannabis evolves, many patients and GPs are beginning to explore whether medical cannabis could offer an alternative. In this instalment of our medical cannabis education series, Dr Elisabeth Philipps is joined by
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
